News

Highlights and publications from Frontage’s experts

方达控股公布2022年中期业绩

See More Info
方达医药收购合研生物，扩展药物早期研究服务

方达医药收购合研生物，扩展药物早期研究服务

方达医药近日宣布收购武汉合研生物医药科技有限公司（“合研生物”）70%股权。

See More Info
Frontage Expands Toxicology Services Through the Acquisition of Experimur.

Frontage Expands Toxicology Services Through the Acquisition of Experimur.

2022年1月11日（美国东部时间），方达医药美国实验室宣布已完成收购Experimur LLC及其附属公司Experimur Properties LLC的交易。

See More Info

Frontage Holdings Announces 2021 Annual Results

收入同比增长46.6%至184.4百万美元
扣除非经营项目影响，经调整净利同比增长58.6%至32.2百万美元
合约未来收益增长至历史新高241.8百万美元
在北美和中国通过内生发展与战略并购
稳步推进一体化药物发现与开发服务平台

See More Info
Featured
Frontage Holdings Announces 2021 Interim Results

Frontage Holdings Announces 2021 Interim Results

See More Info
News
Dr. Raj Yadwad joins Frontage Laboratories as VP Product Development & Manufacturing.

Dr. Raj Yadwad joins Frontage Laboratories as VP Product Development & Manufacturing.

See More Info
Featured
Frontage Opens a New State-of-the-Art Laboratory Facility in Exton, PA

Frontage Opens a New State-of-the-Art Laboratory Facility in Exton, PA

See More Info
News
Larry Veal joins Frontage Laboratories, Inc. as the Senior Vice President of North America Sales and Marketing

Larry Veal joins Frontage Laboratories, Inc. as the Senior Vice President of North America Sales and Marketing

See More Info
Featured
Frontage Laboratories, Inc. to Acquire Quintara Discovery, Inc.

Frontage Laboratories, Inc. to Acquire Quintara Discovery, Inc.

See More Info
en_USEnglish
zh_CNChinese en_USEnglish